Franklin Street Advisors Increases Stake in IDEXX Laboratories

Hedge fund boosts position in veterinary diagnostics company by 9.4%

Apr. 9, 2026 at 8:24am

Got story updates? Submit your updates here. ›

A photorealistic studio shot of a polished metal veterinary diagnostic instrument, a glass beaker, and a tablet computer arranged elegantly on a clean white background, conveying the precision and innovation of the animal health industry.A conceptual still life highlighting the advanced technology and precision of veterinary diagnostics.Westbrook Today

Franklin Street Advisors Inc. NC increased its stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) by 9.4% in the fourth quarter, according to a recent SEC filing. The hedge fund now owns 40,183 shares of the company's stock, worth approximately $27.2 million.

Why it matters

IDEXX Laboratories is a leading provider of diagnostic tools and services for the veterinary industry. The company's stock has been a strong performer, and institutional investors like Franklin Street Advisors are closely watching the company's growth and positioning within the animal health market.

The details

According to the filing, Franklin Street Advisors purchased an additional 3,469 shares of IDEXX Laboratories during the fourth quarter. The hedge fund now owns approximately 0.05% of the company's outstanding shares. IDEXX Laboratories is the 21st largest holding in Franklin Street Advisors' portfolio.

  • The SEC filing was made on April 9, 2026, disclosing the fourth quarter 2025 increase in IDEXX Laboratories shares.

The players

Franklin Street Advisors Inc. NC

A North Carolina-based hedge fund that manages over $2 billion in assets.

IDEXX Laboratories, Inc.

A global leader in veterinary diagnostics, providing in-clinic testing instruments, reference lab services, and practice management software.

Got photos? Submit your photos here. ›

The takeaway

The increased stake by Franklin Street Advisors underscores the strong institutional interest in IDEXX Laboratories as the company continues to grow its presence in the animal health market. This filing provides insight into the investment strategies of major hedge funds and their views on the veterinary diagnostics industry.